Risks are growing that the Federal Reserve could end up delivering either fewer or more rate cuts in 2025 than many people expect, according to Scott Buchta, head of fixed-income strategy for Brean ...

Investors are optimistic that the company can overcome its difficulties following last year’s 40% drop in its stock price, which was mainly due..

Wondering where Apple stock may be in five years? Learn what the current state of AAPL stock is and what its five year ...

Steve Sosnick, chief strategist of Interactive Brokers, pointed out that the previous low for the Michigan data registered on November 30, 2022. That, he observed, turned out to be a “rather opportune ...

Jon Smith talks through a FTSE company that has endured problems but is one he believes has a brighter future than many investors are currently expecting.

Shares of Zscaler (NASDAQ: ZS) have climbed nearly 10% so far this year, partly on the back of a strong financial report for ...

Super Micro Computer (SMCI) stock has been on a roller coaster ride. It has dropped roughly 65% from its 52-week high, ...

Middle East investors are bracing for steep losses and questioning about their long-term investments in America amid a drop ...

Earnings of F.N.B. Corporation will likely rebound this year, mainly on the back of below-average loan growth. Read why I ...

Cameco is a fantastic uranium miner that’s down around 30% from recent highs. If you’re still a believer in a nuclear-powered future, the dip looks like nothing more than an opportunity to buy.

Novo Nordisk shares rose Monday as the company said it would present new data on the ability of semaglutide, the active ingredient in its weight-loss drugs Ozempic and Wegovy, to lower heart risks.